Collegium Pharmaceutical, Inc. COLL Non-cash interest expense
Non-cash interest expense at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s non-cash interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s non-cash interest expense?
- Collegium Pharmaceutical, Inc. (COLL) reported non-cash interest expense of $819K in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s non-cash interest expense changed year-over-year?
- Collegium Pharmaceutical, Inc.'s non-cash interest expense decreased by 40.1% year-over-year, from $1.37M to $819K.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s non-cash interest expense?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s non-cash interest expense has grown at a 11.9% compound annual growth rate (CAGR), from $3.41M to $5.34M.